摘要
肿瘤相关巨噬细胞 (TAM) 位于肿瘤微环境 (TME) 中,在癌细胞存活和进展中发挥重要作用。 TAMs 通过产生炎症介质、生长因子、细胞因子、趋化因子等参与在肿瘤中产生免疫抑制性 TME。TAMs 可以影响肿瘤细胞 (TCs) 的血管生成、转移行为并引起多药耐药性。 TME 内的 TAM 可以增强癌细胞转移,并且是基质和血管周围的。在缺氧和TME的无血管区促进血管生成。 TAM 的分化状态被认为是“可塑性的”,因为它们根据局部线索表现出一种或几种表型的时间表达。新兴的癌症研究描述了巨噬细胞极化(M1、M2)的表观遗传调控及其对开发药理学调节剂和 microRNA 以充当分子开关甚至作为抑制肿瘤生长的靶向疗法的潜在影响。本文讨论了 TAM 在肿瘤进展、血管生成和转移中的作用。此外,还讨论了由 TAM 调节的关键信号级联反应,这些级联反应在化学抗性中发挥作用。目前,各种抗癌植物药物的新型多效特性正变得越来越重要,因为它们有助于克服 TAM 诱导的化学抗性。此外,这些植物药物正在与化疗剂、抗血管生成分子、抗转移化合物和其他针对肿瘤转移/血管生成的免疫检查点阻滞剂一起作为“辅助治疗剂”进行测试。因此,提供了针对 TAM 的天然产物的简要说明。总之,这篇综述将有利于药理学家和医疗专业人员使用多组学方法开发靶向 TAM 的疗法,包括基因组学、表观基因组学、转录组学和蛋白质组学。
关键词: 肿瘤相关巨噬细胞、肿瘤微环境、化学增敏作用、肿瘤血管生成、M1 和 M2、巨噬细胞、天然产物。
Current Medicinal Chemistry
Title:The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status
Volume: 28 Issue: 39
关键词: 肿瘤相关巨噬细胞、肿瘤微环境、化学增敏作用、肿瘤血管生成、M1 和 M2、巨噬细胞、天然产物。
摘要: Tumor associated macrophages (TAMs), located in the tumor microenvironment (TME), play a significant role in cancer cell survival and progression. TAMs have been involved in producing immuno-suppressive TME in the tumor by generating inflammatory mediators, growth factors, cytokines, chemokines, etc. TAMs can influence the angiogenesis, metastatic behavior of tumor cells (TCs) and cause multidrug resistance. TAMs within the TME can enhance cancer cell metastasis and are stromal and perivascular. The angiogenesis is promoted at the hypoxia, and the avascular zones of TME. Differentiation states of TAMs are considered ‘plastic’ as they exhibit temporal expression of one or several phenotypes depending on local cues. Emerging cancer research depicted the epigenetic regulation of macrophage polarization (both M1s, M2s) and their potential implications to develop pharmacologic modulators and microRNAs to act as molecular switches and even to serve as targeted therapies to inhibit tumor growth. In the present article, the role of TAMs in tumor progression, angiogenesis and metastasis was discussed. In addition, key signaling cascades regulated by TAMs, which have a role in chemoresistance, were also discussed. Currently, novel pleiotropic properties of various anticancer phytomedicines are gaining importance as they assist in overcoming TAMs-induced chemoresistance. Moreover, these phytomedicines are being tested as ‘adjunct therapeutics’ along with chemotherapeutic agents, anti-angiogenic molecules, anti-metastatic compounds, and other immune-checkpoint blockers against tumor metastasis/angiogenesis. Hence, a brief note on natural products targeting TAMs was provided. In summary, this review would benefit pharmacologists and medical professionals to develop therapies to target TAMs using multi-OMICs approaches, including genomics, epigenomics, transcriptomics, and proteomics.
Export Options
About this article
Cite this article as:
The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status, Current Medicinal Chemistry 2021; 28 (39) . https://dx.doi.org/10.2174/0929867328666210720143721
DOI https://dx.doi.org/10.2174/0929867328666210720143721 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
[General Articles] Intracellular Thiol Concentration Modulating Inflammatory Response: Influence on the Regulation of Cell Functions Through Cysteine Prodrug Approach
Current Medicinal Chemistry Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Carotenoids and Modulation of Cancer: Molecular Targets
Current Pharmacogenomics Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices
Current Neuropharmacology Biomedical Applications of Poly(Lactic Acid)
Recent Patents on Regenerative Medicine MiRNA-145 and Its Direct Downstream Targets in Digestive System Cancers: A Promising Therapeutic Target
Current Pharmaceutical Design Histone Lysine-Specific Methyltransferases and Demethylases in Carcinogenesis: New Targets for Cancer Therapy and Prevention
Current Cancer Drug Targets Erdafitinib as a Novel and Advanced Treatment Strategy of Metastatic Urothelial Carcinoma
Anti-Cancer Agents in Medicinal Chemistry ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy
Current Pharmaceutical Design A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency
Endocrine, Metabolic & Immune Disorders - Drug Targets Beyond Photodynamic Therapy: Light-Activated Cancer Chemotherapy
Current Medicinal Chemistry The Use of Anthracyclines for Therapy of CNS Tumors
Anti-Cancer Agents in Medicinal Chemistry Molecular Targeting of Drug Delivery Systems to Cancer
Current Drug Targets Microgravity Alters Cancer Growth and Progression
Current Cancer Drug Targets Selective Estrogen Receptor Modulators and Aromatase Inhibitors for Breast Cancer Chemoprevention
Current Drug Targets Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimisation, In-Vitro and In-Vivo Evaluation
Current Drug Delivery Herb-drug Interactions Involving Drug Metabolizing Enzymes and Transporters
Current Drug Metabolism Proline Oxidase (POX) as A Target for Cancer Therapy
Current Drug Targets Schistosoma mansoni Changes the Activity of Phase II Drug-Metabolizing Enzymes: Role of Praziquantel as Antibilharzial Drug
Drug Metabolism Letters